• Identify, assure, and measure major sources of variability affecting the MRI-directed biopsy pathway for prostate cancer diagnosis. • Develop strategies to control and minimize variations that impair pathway effectiveness including the performance of main players and team working. • Assure end-to-end quality of the diagnostic chain with robust multidisciplinary team working.

dx.doi.org/10.1007/s00330-020-07527-9, hdl.handle.net/1765/131849
European Radiology: journal of the European Congress of Radiology
Department of Radiology

Padhani, A, Schoots, I.G, Turkbey, B, Giannarini, G, & Barentsz, J. (2020). A multifaceted approach to quality in the MRI-directed biopsy pathway for prostate cancer diagnosis. European Radiology: journal of the European Congress of Radiology. doi:10.1007/s00330-020-07527-9